Teva Pharmaceutical Industries Limited (TEVA)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$41.96
+0.12%
Mkt Cap $36.69B
Analyst Ratings
No recent rating data.
Price Target (34 analysts)
$44.67
Range $42.00 – $48.00
Implied Upside
+6.5%
Consensus $44.67 vs current $41.96